Joshua Lehrer-Graiwer's Net Worth
$4.98 Million
Who is Joshua Lehrer-Graiwer?
Joshua Lehrer-Graiwer has an estimated net worth of $4.98 Million. This is based on reported shares across multiple companies, which include Graphite Bio, Inc., and Global Blood Therapeutics, Inc..
SEC CIK
Joshua Lehrer-Graiwer's CIK is 0001789673
Past Insider Trading and Trends
2019 was Joshua Lehrer-Graiwer's most active year for acquiring shares with 21 total transactions. Joshua Lehrer-Graiwer's most active month to acquire stocks was the month of October. 2019 was Joshua Lehrer-Graiwer's most active year for disposing of shares, totalling 33 transactions. Joshua Lehrer-Graiwer's most active month to dispose stocks was the month of October. 2019 saw Joshua Lehrer-Graiwer paying a total of $1,587,982.23 for 51,455 shares, this is the most they've acquired in one year. In 2019 Joshua Lehrer-Graiwer cashed out on 87,894 shares for a total of $2,568,842.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Graphite Bio, Inc. (GRPH) Snapshot price: $2.915
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +49.02% | 382.14K |
$0.30 |
—
| 1.16M |
Jan 13 - Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Global Blood Therapeutics, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.48% | -1.14K |
$41.38 | -$111,840.78 | 2.6K |
Scheduled
|
Mar 5 - Mar 9
| ||
Form 4
| +43.85% | 1.14K |
$63.96 | -$39,143.52 | 3.73K |
Mar 1
| |||
Form 4
|
—
|
0
|
$48.30 | -$56,209.53 | 2.6K |
Scheduled
|
Feb 18
| ||
Form 4
| -60.27% | -3.94K |
$42.55 | -$320,995.05 | 2.6K |
Scheduled
|
Feb 6 - Feb 10
| ||
Form 4
| +224.01% | 4.52K |
$57.69 | -$386,290.66 | 6.53K |
Scheduled
|
Jan 31 - Feb 3
| ||
Form 4
|
—
|
0
|
$49.53 | -$33,778.25 | 2.02K |
Scheduled
|
Jan 27
| ||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.02K |
$76.88 | -$152,529.92 | 2.02K |
Dec 13
| |||
Form 4
|
—
|
0
|
$49.20 | -$54,917.57 |
0
|
Scheduled
|
Dec 9
| ||
Form 4
|
—
|
0
|
$53.41 | -$463,551.63 |
0
|
Scheduled
|
Nov 25 - Nov 26
| ||
Form 4
|
—
|
0
|
$50.54 | -$58,613.60 |
0
|
Scheduled
|
Nov 18 - Nov 19
| ||
Form 4
|
—
|
0
|
$37.78 | -$251,247.68 |
0
|
Scheduled
|
Nov 14 - Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |